Seeking Alpha

The FDA approves Medtronic's (MDT +0.1%) Advisa DR MRI SureScan pacing system, the company's...

The FDA approves Medtronic's (MDT +0.1%) Advisa DR MRI SureScan pacing system, the company's next-generation pacemaker that enables patients to receive MRI scans, something that is not allowed with traditional pacemakers. It's worth noting that up to 75% of patients with implanted heart devices worldwide are expected to need an MRI scan during the lifetime of those devices. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector